DOCSLIB.ORG

R Medicine (General) Periodicals. Societies. Serials 5 International

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
R Medicine (General) Periodicals. Societies. Serials 5 International R MEDICINE (GENERAL) R Medicine (General) Periodicals. Societies. Serials 5 International periodicals and serials 10 Medical societies Including aims, scope, utility, etc. International societies 10.5.A3 General works 10.5.A5-Z Individual societies America English United States. Canada 11 Periodicals. Serials 15 Societies British West Indies. Belize. Guyana 18 Periodicals. Serials 20 Societies Spanish and Portuguese Latin America 21 Periodicals. Serials 25 Societies 27.A-Z Other, A-Z 27.F7 French Europe English 31 Periodicals. Serials 35 Societies Dutch 37 Periodicals. Serials 39 Societies French 41 Periodicals. Serials 45 Societies German 51 Periodicals. Serials 55 Societies Italian 61 Periodicals. Serials 65 Societies Spanish and Portuguese 71 Periodicals. Serials 75 Societies Scandinavian 81 Periodicals. Serials 85 Societies Slavic 91 Periodicals. Serials 95 Societies 1 R MEDICINE (GENERAL) R Periodicals. Societies. Serials Europe -- Continued 96.A-Z Other European languages, A-Z 96.H8 Hungarian Asia 97 English 97.5.A-Z Other European languages, A-Z 97.7.A-Z Other languages, A-Z Africa 98 English 98.5.A-Z Other European languages, A-Z 98.7.A-Z Other languages, A-Z Australasia and Pacific islands 99 English 99.5.A-Z Other European languages, A-Z 99.7.A-Z Other languages, A-Z Indexes see Z6658+ (101) Yearbooks see R5+ 104 Calendars. Almanacs Cf. AY81.M4 American popular medical almanacs 106 Congresses 108 Medical laboratories, institutes, etc. Class here papers and proceedings For works about these organizations see R860+ Collected works (nonserial) Cf. R126+ Ancient Greek and Latin works 111 Several authors 114 Individual authors Communication in medicine Cf. PN4192.M43 Public speaking 118 General works Information centers 118.2 General works 118.4.A-Z By region or country, A-Z 118.6 Medical literature 119 Medical writing. Abstracting and indexing Including practical manuals and stylebooks Cf. PE1475 Preparation of scientific papers in English Cf. PN4784.M4 Medical journalism Cf. R853.P75 Proposal writing 119.5 Medical translating. Translating services Medical illustration see R836.A1+ 119.8 Medical archives Medical telecommunication. Television in medicine 119.9 General works 119.95 Medical telematics 2 R MEDICINE (GENERAL) R 120 Atlases. Pictorial works 121 Dictionaries 123 Nomenclature. Terminology. Abbreviations Cf. RB115 Pathology 125 Encyclopedias General works Through 1800 126.A-Z Ancient Greek 126.A1A-.A1Z Collected works 126.A1C6 Corpus medicorum graecorum 126.A2-Z Individual works Archigenes 126.A6 Collected or selected works. By date 126.A7A-.A7Z Individual works. By title, A-Z 126.A8 Biography and criticism Dioscorides Pedanius, of Anazarbos 126.D5-.D6 Works 126.D7 Biography and criticism For philological and textual criticism see PA3968.D6 Galen 126.G2-.G7 Works 126.G8 Biography and criticism For philological and textual criticism see PA3997 Hippocrates Collected and selected works By date 126.H4 Greek 126.H5 Greek and Latin 126.H51 Latin 126.H54 English 126.H55 French 126.H56 German 126.H57 Other 126.H59 Selections. By editor or compiler 126.H6A-.H6Z Individual works, A-Z 126.H6A3-.H6A5 De aere, aquis et locis 126.H6A6-.H6A9 Aphorismi 126.H6C3 De capitis vulneribus 126.H6E6 Epidemiorum libri (I and III) 126.H6F7 De fracturis 126.H6H2 De haemorrhoidibus Jusjurandum see R724.5 126.H6L6 Lex 126.H6M6 Mochlicus 126.H6M8 De morbo sacro De prisca medicina see R126.H7P6 3 R MEDICINE (GENERAL) R General works Through 1800 Ancient Greek Individual works Hippocrates Individual works, A-Z -- Continued 126.H6P8 Prognostica 126.H6U8 De ulceribus 126.H6V6 De victus ratione in morbis acutis 126.H6V85 De vulneribus et telis 126.H7A-.H7Z Spurious and doubtful works, A-Z 126.H7A1 Collected works 126.H7A4 De alimento 126.H7A7 De articulis 126.H7C5 Coacae praenotiones 126.H7C7 De corde 126.H7D3 De decenti habitu 126.H7E2 Epidemiorum libri (II) 126.H7E4 Epidemiorum libri (IV) 126.H7E5 Epidemiorum libri (V) 126.H7E6 Epidemiorum libri (VI) 126.H7E7 Epidemiorum libri (VII) 126.H7F6 De flatibus 126.H7G3 De genitura 126.H7G5 On glands 126.H7H8 De humoribus 126.H7I5 De insomniis 126.H7I7 De internis affectionibus 126.H7L8 De locis in homine 126.H7M3 De medicamentis purgatoriis 126.H7M5 De medicorum astrologia 126.H7M7 De morbis 126.H7M9 De mulierum morbis 126.H7N3 De natura humana 126.H7P57 Peri technēs 126.H7P6 De prisca medicina 126.H7S5 De septimanus 126.H8 Works about Hippocrates For philological and textual criticism see PA4016 126.M52 Michigan Medical Codex 126.P37 Paul of Niceae 126.P4 Paulus, Aegineta 126.P7 Praxagoras Ancient Latin 127.A1A-.A1Z Collected works 127.A1C6 Corpus medicorum latinorum 127.A2-Z Individual works 4 R MEDICINE (GENERAL) R General works Through 1800 Ancient Latin Individual works -- Continued 127.C2-.C6 Celsus 127.C2-.C5 Works 127.C6 Biography and criticism For philological and textual criticism see PA6277.C3 127.1 Ancient Chinese works 127.2 Ancient Indic works 127.3 Ancient Egyptian works 127.5 Other ancient works Medieval works Class here works chiefly in medieval Latin 128 General works 128.3 Arabic Early modern works 128.6 15th-16th centuries 128.6.P2-.P33 Paracelsus Cf. R147.P2 Biography 128.7 17th-18th centuries 1801- 129 Comprehensive systematic works 130 Theories. Principles Cf. R733 Special schools and theories of medicine 130.3 Outlines, syllabi, etc. 130.5 Juvenile works Addresses, essays, lectures see R708 History Cf. GN477+ Primitive medicine Cf. GR880 Folk medicine 131.A1 Periodicals. Societies. Serials 131.A2 Congresses 131.A3-Z General works 133 General special 133.5 Juvenile works 133.6 Addresses, essays, lectures Biography For biography of specialists in particular fields, see the field, e.g., Ophthalmology RE31+ For medical missionaries see R722.3+ Collective 134 General 134.5 Collections of portraits Individual and national biography see R153+ By period 5 R MEDICINE (GENERAL) R History By period -- Continued Paleopathology 134.8 General works Biography 134.85 Collective 134.86.A-Z Individual, A-Z Ancient Biography see R126.A+ 135 General works 135.3 Assyro-Babylonian medicine 135.5 Biblical and Talmudic medicine 135.6 Buddhist medicine 135.8 Shinto medicine 137 Egyptian medicine 137.3 Minoan medicine 137.5 Scythian medicine 137.8 Persian medicine 138 Greek medicine 138.5 Roman medicine Medieval 141 General works 143 Arabic Biography 144.A1 Collective 144.A2-Z Individual, A-Z 144.A7 Arnaldus de Villanova Modern 145 General works 15th-16th centuries 146 General works Biography 147.A1 Collective 147.A2-Z Individual, A-Z 147.P2 Paracelsus Cf. BF1598.P2 Hermetic philosophy Cf. R128.6.P2+ Medical works 17th-18th centuries 148 General works Biography see R134+; R153+ 19th-20th centuries 149 General works Biography see R134+; R153+ By region or country 150 America United States 151 General works 6 R MEDICINE (GENERAL) R History By region or country United States -- Continued 152 General special Biography Collective 153 General 153.5 Collections of portraits 154.A-Z Individual, A-Z 154.5.A-Z By region, A-Z For biography see R153+ For local see R155+ By state 155-157 Alabama (Table R2) 159-161 Alaska (Table R2) 163-165 Arizona (Table R2) 167-169 Arkansas (Table R2) 171-173 California (Table R2) 175-177 Colorado (Table R2) 184-186 Connecticut (Table R2) 188-190 Delaware (Table R2) 193-195 District of Columbia (Table R2) 197-199 Florida (Table R2) 201-203 Georgia (Table R2) Hawaii 204 General works 204.2.A-Z Local, A-Z 204.3 Collective biography For individual biography, see R154.A+ 205-207 Idaho (Table R2) 209-211 Illinois (Table R2) 217-219 Indiana (Table R2) 221-223 Iowa (Table R2) 225-227 Kansas (Table R2) 229-231 Kentucky (Table R2) 233-235 Louisiana (Table R2) 237-239 Maine (Table R2) 241-243 Maryland (Table R2) 245-247 Massachusetts (Table R2) 249-251 Michigan (Table R2) 254-256 Minnesota (Table R2) 258-260 Mississippi (Table R2) 263-265 Missouri (Table R2) 267-269 Montana (Table R2) 271-273 Nebraska (Table R2) 275-277 Nevada (Table R2) 279-281 New Hampshire (Table R2) 7 R MEDICINE (GENERAL) R History By region or country United States By state -- Continued 283-285 New Jersey (Table R2) 287-289 New Mexico (Table R2) 291-293 New York (Table R2) 294-296 North Carolina (Table R2) 297-299 North Dakota (Table R2) 301-303 Ohio (Table R2) 305-307 Oklahoma (Table R2) 309-311 Oregon (Table R2) 313-315 Pennsylvania (Table R2) 317-319 Rhode Island (Table R2) 321-323 South Carolina (Table R2) 325-327 South Dakota (Table R2) 329-331 Tennessee (Table R2) 333-335 Texas (Table R2) 337-339 Utah (Table R2) 341-343 Vermont (Table R2) 345-347 Virginia (Table R2) 349-351 Washington (Table R2) 353-355 West Virginia (Table R2) 357-359 Wisconsin (Table R2) 361-363 Wyoming (Table R2) Other regions or countries 461-464 Canada (Table R3) 464.2 Greenland Latin America 464.5 General works 465-468 Mexico (Table R3) Central America 469 General works 471.A-Z By region or country, A-Z Biography 472.A1 Collective 472.A2-Z Individual, A-Z West Indies 473 General works 475.A-Z By region or country, A-Z Biography 476.A1 Collective 476.A2-Z Individual, A-Z South America 480 General works 482.A-Z By region or country, A-Z Biography 8 R MEDICINE (GENERAL) R History By region or country Other regions or countries Latin America South America Biography -- Continued 483.A1 Collective 483.A2-Z Individual, A-Z Europe 484 General works 486-489 Great Britain. England (Table R3) 491-493 Northern Ireland (Table R3 modified) Biography 494.A1 Collective see R489.A1 Individual, A-Z see R489.A2+ 495-497 Scotland (Table R3 modified) Biography 498.A1 Collective see R489.A1 Individual, A-Z see R489.A2+ 498.2-.4 Wales (Table R3 modified) Biography 498.5.A1 Collective see R489.A1 Individual, A-Z see R489.A2+ 498.6-.9 Ireland (Table R3) 499-502 Austria (Table R3) 504-507 France (Table R3) Biography 507.A1 Collective 507.A2-Z Individual, A-Z Schweitzer, Albert see R722.32.S35 509-512 Germany (Table R3) Including West Germany 512.2-.5 East Germany (Table R3) 513-516 Greece (Table R3) 517-520 Italy (Table R3) Benelux countries.
Load more

Recommended publications
  • Overexpression of Cx43 in Cells of the Myocardial Scar
    www.nature.com/scientificreports OPEN Overexpression of Cx43 in cells of the myocardial scar: Correction of post-infarct arrhythmias through Received: 27 September 2017 Accepted: 6 April 2018 heterotypic cell-cell coupling Published: xx xx xxxx Wilhelm Roell1, Alexandra M. Klein1,2, Martin Breitbach2, Torsten S. Becker2, Ashish Parikh4, Jane Lee3, Katrin Zimmermann5, Shaun Reining3, Beth Gabris4, Annika Ottersbach1,2, Robert Doran3, Britta Engelbrecht1,2, Miriam Schifer1,2, Kenichi Kimura1,2, Patricia Freitag2, Esther Carls1,2, Caroline Geisen2, Georg D. Duerr1, Philipp Sasse2, Armin Welz1, Alexander Pfeifer5, Guy Salama4, Michael Kotlikof3 & Bernd K. Fleischmann2 Ventricular tachycardia (VT) is the most common and potentially lethal complication following myocardial infarction (MI). Biological correction of the conduction inhomogeneity that underlies re- entry could be a major advance in infarction therapy. As minimal increases in conduction of infarcted tissue markedly infuence VT susceptibility, we reasoned that enhanced propagation of the electrical signal between non-excitable cells within a resolving infarct might comprise a simple means to decrease post-infarction arrhythmia risk. We therefore tested lentivirus-mediated delivery of the gap-junction protein Connexin 43 (Cx43) into acute myocardial lesions. Cx43 was expressed in (myo)fbroblasts and CD45+ cells within the scar and provided prominent and long lasting arrhythmia protection in vivo. Optical mapping of Cx43 injected hearts revealed enhanced conduction velocity within the scar, indicating Cx43-mediated electrical coupling between myocytes and (myo)fbroblasts. Thus, Cx43 gene therapy, by direct in vivo transduction of non-cardiomyocytes, comprises a simple and clinically applicable biological therapy that markedly reduces post-infarction VT. Ventricular tachycardia (VT) is the most common and potentially lethal complication following myocardial infarction (MI)1.
    [Show full text]
  • Pain Management E-Book
    VetEdPlus E-BOOK RESOURCES Pain Management E-Book WHAT’S INSIDE Gabapentin and Amantadine for Chronic Pain: Is Your Dose Right? Grapiprant for Control of Osteoarthritis Pain in Dogs Use of Acupuncture for Pain Management Regional Anesthesia for the Dentistry and Oral Surgery Patient A SUPPLEMENT TO Laser Therapy for Treatment of Joint Disease in Dogs and Cats Manipulative Therapies for Hip and Back Hypomobility in Dogs E-BOOK PEER REVIEWED CONTINUING EDUCATION Gabapentin and Amantadine for Chronic Pain: Is Your Dose Right? Tamara Grubb, DVM, PhD, DACVAA Associate Professor, Anesthesia and Analgesia Washington State University College of Veterinary Medicine Pain is not always a bad thing, and all pain is not Untreated or undertreated pain can cause myriad the same. Acute (protective) pain differs from adverse effects, including but not limited to chronic (maladaptive) pain in terms of function insomnia, anorexia, immunosuppression, and treatment. This article describes the types of cachexia, delayed wound healing, increased pain pain, the reasons why chronic pain can be sensation, hypertension, and behavior changes difficult to treat, and the use of gabapentin and that can lead to changes in the human–animal amantadine for treatment of chronic pain. bond.2 Hence, we administer analgesic drugs to patients with acute pain, not to eliminate the protective portion but to control the pain ACUTE PAIN beyond that needed for protection (i.e., the pain Acute pain in response to tissue damage is often that negatively affects normal physiologic called protective pain because it causes the processes and healing). This latter type of pain patient to withdraw tissue that is being damaged decreases quality of life without providing any to protect it from further injury (e.g., a dog adaptive protective mechanisms and is thus withdrawing a paw after it steps on something called maladaptive pain.
    [Show full text]
  • Radiation Protection Guidance for Diagnostic X Rays
    Disclaimer - For assistance accessing this document or additional information, please contact [email protected]. EPA 520/4-76-019 FEDERAL GUIDANCE REPORT NO. 9 RADIATION PROTECTION GUIDANCE FOR DIAGNOSTIC X RAYS ENVIRONMENTAL PROTECTION AGENCY INTERAGENCY WORKING GROUP ON MEDICAL RADIATION FEDERAL GUIDANCE REPORT NO. 9 RADIATION PROTECTION GUIDANCE FOR DIAGNOSTIC X RAYS Interagency Working Group on Medical Radiation U.S. Environmental Protection Agency Washington, D.C. 20460 October 1976 PREFACE The authority of the Federal Radiation Council to provide radiation protection guidance was transferred to the Environmental Protection Agency on December 2, 1970, by Reorganization Plan No. 3. Prior to this transfer, the Federal Radiation Council developed reports which provided the basis for guidance recommended to the President for use by Federal agencies in developing standards for a wide range of radiation exposure circumstances. This report, which was prepared in cooperation with an Interagency Working Group on Medical Radiation formed on July 5, 1974, constitutes a similar objective to provide the basis for recommendations to reduce unnecessary radiation exposure due to medical uses of diagnostic x rays. The Interagency Working Group developed its recommendations with the help of two subcommittees. The Subcommittee on Prescription of Exposure to X rays examined factors to eliminate clinically unproductive examinations and the Subcommittee on Technic of Exposure Prevention examined factors to assure the use of optimal technic in performing x-ray examinations. Both subcommittees also considered the importance of appropriate and properly functioning equipment in producing radiographs of the required diagnostic quality with minimal exposure. Reports by these subcommittees were made available for public comment.
    [Show full text]
  • The Dangerous Discourse of Dianetics: Linguistic Manifestations of Violence Toward Queerness in the Canonical Religious Philosophy of Scientology
    Relics, Remnants, and Religion: An Undergraduate Journal in Religious Studies Volume 2 Issue 2 Article 4 5-5-2017 The Dangerous Discourse of Dianetics: Linguistic Manifestations of Violence Toward Queerness in the Canonical Religious Philosophy of Scientology Francesca Retana University of Puget Sound, [email protected] Follow this and additional works at: https://soundideas.pugetsound.edu/relics Recommended Citation Retana, Francesca (2017) "The Dangerous Discourse of Dianetics: Linguistic Manifestations of Violence Toward Queerness in the Canonical Religious Philosophy of Scientology," Relics, Remnants, and Religion: An Undergraduate Journal in Religious Studies: Vol. 2 : Iss. 2 , Article 4. Available at: https://soundideas.pugetsound.edu/relics/vol2/iss2/4 This Article is brought to you for free and open access by the Student Publications at Sound Ideas. It has been accepted for inclusion in Relics, Remnants, and Religion: An Undergraduate Journal in Religious Studies by an authorized editor of Sound Ideas. For more information, please contact [email protected]. Retana: The Dangerous Discourse of Dianetics: Linguistic Manifestations Page 1 of 45 The Dangerous Discourse of Dianetics: Linguistic Manifestations of Violence Toward Queerness in the Canonical Religious Philosophy of Scientology I. Uncovering the Anti-Queer Sentiment in the Dianetic Perspective At present, there is a groundswell of public sensational interest in the subject of Scientology; and, in fact, in the time since I began this research paper, a nine-episode documentary series has premiered and reached finale on A&E titled “Scientology and the Aftermath”— a personal project hosted by sitcom celebrity, ex-Scientologist, and author of Troublemaker: Surviving Hollywood and Scientology, Leah Remini.1 I could not begin to enumerate the myriad exposés/memoirs of ex-Scientologists that have been published in recent years nor could I emphasize enough the rampant conspiracy theories that are at the disposal of any curious mind on what many have termed “the cult” of Scientology.
    [Show full text]
  • Cone Beam Computed Tomography (CBCT) Page 1 of 13
    Cone Beam Computed Tomography (CBCT) Page 1 of 13 Dental Policy An Independent licensee of the Blue Cross Blue Shield Association Title: Cone Beam Computed Tomography (CBCT) Professional Institutional Original Effective Date: January 1, 2007 Original Effective Date: January 1, 2007 Revision Date(s): May 14, 2013; Revision Date(s): May 14, 2013; December 31, 2013; May 13, 2015; December 31, 2013; May 13, 2015; April 27, 2016; January 18, 2017; April 27, 2016; January 18, 2017; February 15, 2018; July 3, 2019; February 15, 2018; July 3, 2019, October 1, 2020; May 21, 2021 October 1, 2020; May 21, 2021 Current Effective Date: May 21, 2021 Current Effective Date: May 21, 2021 State and Federal mandates and health plan member contract language, including specific provisions/exclusions, take precedence over Medical Policy and must be considered first in determining eligibility for coverage. To verify a member's benefits, contact Blue Cross and Blue Shield of Kansas Customer Service. The BCBSKS Medical Policies contained herein are for informational purposes and apply only to members who have health insurance through BCBSKS or who are covered by a self-insured group plan administered by BCBSKS. Medical Policy for FEP members is subject to FEP medical policy which may differ from BCBSKS Medical Policy. The medical policies do not constitute medical advice or medical care. Treating health care providers are independent contractors and are neither employees nor agents of Blue Cross and Blue Shield of Kansas and are solely responsible for diagnosis, treatment and medical advice. If your patient is covered under a different Blue Cross and Blue Shield plan, please refer to the Medical Policies of that plan.
    [Show full text]
  • Breast Cancer Detection from a Urine Sample by Dog Sni Ng
    Breast Cancer Detection from a Urine Sample by Dog Sning Shoko Kure ( [email protected] ) Nihon Ika Daigaku https://orcid.org/0000-0002-9536-9438 Shinya Iida Nippon Medical School Chiba Hokusoh Hospital, Department of Breast Oncology Marina Yamada Nippon Sport Science University, Faculty of Medical Science Hiroyuki Takei Nippon Medical School Hospital, Department of Breast Surgery Naoyuki Yamashita Jizankai Medical foundation Tsuboi Cancer Center Hospital Yuji Sato St. Sugar Canine Cancer Detection Training Center Masao Miyashita Nippon Medical School and Twin Peaks Laboratory of Medicine Research article Keywords: dogs, diagnosis, canine cancer detection, breast cancer, urine sample Posted Date: October 14th, 2020 DOI: https://doi.org/10.21203/rs.3.rs-89484/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/11 Abstract Background: Breast cancer is a leading cause of cancer death worldwide. Several studies have demonstrated that dog can sniff and detect cancer in the breath or urine sample of a patient. Objective: The aim of this study is to assess whether the trained dog can detect breast cancer from urine samples. Methods: A nine-year-old female Labrador Retriever was trained to identify cancer from urine samples of breast cancer patients. Urine samples from patients histologically diagnosed with primary breast cancer, those with non-breast malignant diseases, and healthy volunteers were obtained, and a double-blind test was performed. Results: 40 patients with breast cancer, 142 patients with non-breast malignant diseases, and 18 healthy volunteers were enrolled, and their urine samples were collected.
    [Show full text]
  • Evaluation of the Optimal Image Reconstruction Interval for Noninvasive Coronary 64-Slice Computed Tomography Venography
    Open Journal of Radiology, 2013, 3, 66-72 http://dx.doi.org/10.4236/ojrad.2013.32010 Published Online June 2013 (http://www.scirp.org/journal/ojrad) Evaluation of the Optimal Image Reconstruction Interval for Noninvasive Coronary 64-Slice Computed Tomography Venography Yasutoshi Ohta1, Shinya Fujii1, Suguru Kakite1, Einosuke Mizuta2, Masayuki Hashimoto3, Toshio Kaminou1, Toshihide Ogawa1 1Division of Radiology, Department of Pathophysiological Therapeutic Science, Faculty of Medicine, Tottori University, Yonago City, Japan 2Division of Cardiology, Sanin Rosai Hospital, Yonago City, Japan 3Division of Radiology, Tottori Prefecture Kousei Hospital, Kurayoshi City, Japan Email: [email protected] Received March 22, 2013; revised April 22, 2013; accepted April 30, 2013 Copyright © 2013 Yasutoshi Ohta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Objective: We investigated the appropriate reconstruction interval required to generate optimal quality images of the coronary veins and to evaluate the size of each vein at the systolic and diastolic phases using coronary computed tomo- graphy (CT) venography. Methods: Coronary CT venograms obtained from 30 patients using 64-slice CT were recon- structed at 0% to 90% of the cardiac cycle in 10% increments. Two radiologists assessed the image quality of the ante- rior interventricular vein (AIV), the great cardiac vein (GCV), the posterior vein of the left ventricle (PVLV), the poste- rior interventricular vein (PIV), the coronary sinus (CS) and the small cardiac vein (SCV). We determined the sizes of measurable CS (n = 16) and GCV (n = 12) at the end systolic and mid diastolic phases.
    [Show full text]
  • Review Cutaneous Patterns Are Often the Only Clue to a a R T I C L E Complex Underlying Vascular Pathology
    pp11 - 46 ABstract Review Cutaneous patterns are often the only clue to a A R T I C L E complex underlying vascular pathology. Reticulate pattern is probably one of the most important DERMATOLOGICAL dermatological signs of venous or arterial pathology involving the cutaneous microvasculature and its MANIFESTATIONS OF VENOUS presence may be the only sign of an important underlying pathology. Vascular malformations such DISEASE. PART II: Reticulate as cutis marmorata congenita telangiectasia, benign forms of livedo reticularis, and sinister conditions eruptions such as Sneddon’s syndrome can all present with a reticulate eruption. The literature dealing with this KUROSH PARSI MBBS, MSc (Med), FACP, FACD subject is confusing and full of inaccuracies. Terms Departments of Dermatology, St. Vincent’s Hospital & such as livedo reticularis, livedo racemosa, cutis Sydney Children’s Hospital, Sydney, Australia marmorata and retiform purpura have all been used to describe the same or entirely different conditions. To our knowledge, there are no published systematic reviews of reticulate eruptions in the medical Introduction literature. he reticulate pattern is probably one of the most This article is the second in a series of papers important dermatological signs that signifies the describing the dermatological manifestations of involvement of the underlying vascular networks venous disease. Given the wide scope of phlebology T and its overlap with many other specialties, this review and the cutaneous vasculature. It is seen in benign forms was divided into multiple instalments. We dedicated of livedo reticularis and in more sinister conditions such this instalment to demystifying the reticulate as Sneddon’s syndrome. There is considerable confusion pattern.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • Electropathy
    RNI No. DELBIL/2012/45560 Monthly Newspaper Vol - 2, Issue - 12 DL(E)-20/5415/2012-14 June 1st - 30th, 2014 • ` 10/- • New Delhi Health news delivered daily at drugtodayonline.com Ph.: (011) 22792078, 22792554 DRUG TODAY MedicalMedicalMedical TimesTimesTimes Medical City P2 Medical pharmacy P4 Medical Review P6 DTMT Exclusive P14 Dearth of equipment: Draft new rules in place to Special review on World No Biological clock: Time to Hospitals put on notice amend D&C rules 1945 Tobacco Day (May 31, 2014) listen to body’s rhythm How do I Market my PRODUCT? scan now Drug Today Mart Electropathy in practice even In UP, dirty flows as MoHFW has reservations Ganga sans STPs MK SINGH In what could be a major viola- Only 17 of 742 cities of state boast of sewage treatment plants tion of the rules prescribed by the Union Health Ministry, it has BS RAWAT Gorakhpur, Bijnor, Badaun, Ali- come to light that almost 2 to 3 LUCKNOW garh, Jaunpur, Rai Bareli, Pratap- lakh ‘doctors’ are practicing elec- garh, Shahjahanpur, Mathura, Fi- tropathy or electrohomeopathy. ttar Pradesh Pollution rozabad, Faizabad, Pilibhit, Etah, It is learnt through an RTI query Control Board (UPPCC) Etawah, Baghpat, Bahraich and filed by Chikitsa Sansar, a health is a statutory body en- Hardoi have yet to come up with advocacy group, that 100 to 150 trusted with the powers sewage treatment plants. colleges are offering a full-time Uto deal with the pollution prob- In the absence of sewage treat- four-year course in electropathy lems of the state under the Envi- ment plants, untreated sewage sans recognition.
    [Show full text]
  • Paradigm Evolution of the Traditional Chinese Medicine and Its Application in International Community
    Central Annals of Community Medicine and Practice Case Study *Corresponding author Hui Yang, Department of Primary Health Care, Monash Paradigm Evolution of the University Australia, Melbourne, Australia, Email: Submitted: 14 July 2015 Traditional Chinese Medicine Accepted: 14 August 2015 Published: 16 August 2015 Copyright and its Application in © 2015 Yang et al. International Community OPEN ACCESS 1,2 2 3 4 Keywords Minmei He , Hui Yang *, Shane Thomas , Colette Browning , • Traditional chinese medicine Kendall Searle2 and Wentian Lu5 and Tao Li1 • Paradigm evolution 1Department of Health Services, Beijing University of Chinese Medicine, China • Classification 2Department of Primary Health care, Monash University, Australia • Application 3The University of Adelaide, Australia 4Royal District Nursing Service Australia, Australia 5University College London, UK Abstract Objective: This paper aims to explore the definition, historical development, category and international application of TCM to help the world understand the TCM better. Method: The research searched the database of CNKI (China National Knowledge Infrastructure), web of WHO and the textbook related with TCM by the keywords such as ‘Traditional Chinese Medicine’, ‘Traditional Medicine’, ‘history’, ‘utilization’, ‘classification’, and analyzed the material and made a conclusion. Result: The term of Traditional Chinese Medicine (TCM) was named after the People’s Republic of China was set up; The four famous works built up the fundamental of theory and ideology of medicine in China, which are ‘Huang Di Nei Jing’, ‘Nan Jing’, ‘Shen Nong Bai Cao Jing’ and ‘Shang Han Zai Bing Lun’; The paper classified TCM into two different ways, one is based on the theory difference, the other is based on the life cycle of disease; TCM is well accepted by the world with its effectiveness.
    [Show full text]